載入...
Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases
The emerging role for CD73 in driving cancer growth and metastasis has presented opportunities to develop anti-CD73 monoclonal antibodies (mAbs) in the treatment of human cancers. Blockade of CD73 by antagonistic CD73 mAbs ameliorates tumor growth and metastasis via the inhibition of enzymatic and n...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5467999/ https://ncbi.nlm.nih.gov/pubmed/28638737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1312044 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|